Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v1-EN
Language French English
Date Updated 2019-02-04 2018-06-14
Drug Identification Number 02285630 02285630
Brand name RAN-CITALO RAN-CITALO
Common or Proper name CITALOPRAM CITALOPRAM
Company Name RANBAXY PHARMACEUTICALS CANADA INC. RANBAXY PHARMACEUTICALS CANADA INC.
Ingredients CITALOPRAM CITALOPRAM
Strength(s) 40MG 40MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N06AB N06AB
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-11-23 2018-06-07
Actual start date 2018-11-28 2018-06-14
Estimated end date Unknown 2018-07-06
Actual end date 2018-12-03
Shortage status Resolved Anticipated shortage
Company comments
Health Canada comments